AOD9604Research compoundARA-290Phase 2ArgirelineResearch compoundBPC-157Research compoundCagrilintidePhase 3CJC-1295Research compoundDihexaPreclinicalEpitalonResearch compoundGHK-CuResearch compoundGHRP-2Research compoundGHRP-6Research compoundHexarelinResearch compoundHumaninPreclinicalIpamorelinResearch compoundKPVResearch compoundLiraglutideApprovedLL-37PreclinicalMatrixylResearch compoundMelanotan IIResearch compoundMOTS-cPreclinicalPT-141ApprovedRetatrutidePhase 3SelankResearch compoundSemaglutideApprovedSemaxResearch compoundSermorelinResearch compoundSS-31Phase 3SurvodutidePhase 3TB-500Research compoundTesamorelinApprovedThymosin Alpha-1ApprovedTirzepatideApprovedAOD9604Research compoundARA-290Phase 2ArgirelineResearch compoundBPC-157Research compoundCagrilintidePhase 3CJC-1295Research compoundDihexaPreclinicalEpitalonResearch compoundGHK-CuResearch compoundGHRP-2Research compoundGHRP-6Research compoundHexarelinResearch compoundHumaninPreclinicalIpamorelinResearch compoundKPVResearch compoundLiraglutideApprovedLL-37PreclinicalMatrixylResearch compoundMelanotan IIResearch compoundMOTS-cPreclinicalPT-141ApprovedRetatrutidePhase 3SelankResearch compoundSemaglutideApprovedSemaxResearch compoundSermorelinResearch compoundSS-31Phase 3SurvodutidePhase 3TB-500Research compoundTesamorelinApprovedThymosin Alpha-1ApprovedTirzepatideApproved

Studies

The papers I'm actually reading. Recent research on every compound here, newest first. Read the abstracts before you trust anyone's marketing.

StudyCarbohydrate polymers · 2026-10-01

A tea exosome-integrated self‑oxygenating cascade chitosan/oxidized alginate hydrogel for remodeling the hyperglycemic and hypoxic microenvironment in diabetic wound healing

StudyJournal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia · 2026-10-01

Phase III Open-Label, Randomized Clinical Trial of Epidermal Growth Factor and Growth Hormone Releasing Hexapeptide in Acute Ischemic Stroke

StudyEuropean journal of pharmacology · 2026-08-28

S14G-humanin (HNG) ameliorates diabetic nephropathy tubular injury by inhibiting Z-DNA/ZBP1-mediated necroptosis

StudyNaunyn-Schmiedeberg's archives of pharmacology · 2026-08-22

Psychiatric and eye disorders associated with use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs)

StudyAdvances in therapy · 2026-08-22

Risk of protein intake deficiency during treatment with GLP-1 and GIP/GLP-1 receptor agonists: considerations for secondary sarcopenia

StudyCurrent psychiatry reports · 2026-08-21

GLP-1 and dual GIP/GLP-1 receptor agonists' psychopharmacology and putative neuropsychiatric associated effects: a Bradford Hill-informed, systematic, evaluation

StudyScience advances · 2026-08-21

A multi-functional oral small molecule targeting energy and lipid metabolism to treat obesity and related metabolic disorders

StudyJournal of the European Academy of Dermatology and Venereology : JEADV · 2026-08-21

GLP-1 and GLP-1/GIP agonists in psoriasis: A real-world cohort study on healthcare resource usage

StudyInflammatory bowel diseases · 2026-08-21

GLP-1 receptor agonist therapy is associated with increased symptomatic remission in ulcerative colitis: a matched cohort study

StudyJournal of basic and clinical physiology and pharmacology · 2026-08-21

Protective and restorative effects of hexarelin on MPTP-induced lung injury in mice

StudyAesthetic surgery journal · 2026-08-20

The Regenerative Potential of GHK-Cu in Aesthetic Medicine

StudyAnalytical methods : advancing methods and applications · 2026-08-20

Comprehensive characterization of bremelanotide acetate and its degradants by LC-HRMS/MS and predicting epimerization through computational modelling

StudyeLife · 2026-08-18

MOTS-c is a mitochondrial-encoded interferon-linked host defense peptide

StudyDiabetes, obesity & metabolism · 2026-08-17

Retatrutide-Associated Improvements in Cardiovascular Risk Biomarkers in Adults With Obesity With or Without Type 2 Diabetes

StudyMolecular biomedicine · 2026-08-17

Recombinant human Thymosin β4 ameliorates experimental colitis and intestinal fibrosis through suppression of mineralocorticoid receptor signaling

StudyNaunyn-Schmiedeberg's archives of pharmacology · 2026-08-17

Maximizing weight loss with cagrisema: a systematic review and GRADE-assessed meta-analysis of randomized controlled trials

StudyPhysiology & behavior · 2026-08-15

Co-agonism of GLP-1R and CTR/AMYR in the lateral dorsal tegmental nucleus produces additive effects on homeostatic and motivated feeding

StudyDiabetes therapy : research, treatment and education of diabetes and related disorders · 2026-08-14

Survodutide for Obesity in Chinese Adults: Phase 3 Randomized Trial Design and Baseline Characteristics (SYNCHRONIZE™-CN)

StudyiScience · 2026-08-13

Comparative effects of semaglutide tirzepatide and retatrutide on renal fibrosis in UUO and aged mice

StudyJournal of medicinal chemistry · 2026-08-13

Goldilocks-Inspired Design of Mid-Size Macrocycles for Selective Targeting of Human Melanocortin Receptors

StudyPharmacological research · 2026-08-12

Beyond GLP-1: Amylin-based pharmacotherapy and the search for better-tolerated weight-loss drugs

StudyThe American journal of sports medicine · 2026-08-11

Peptide Supplements and Their Therapeutic Applications in Sports Medicine

StudyEpigenomics · 2026-08-10

Emerging regulators of human physiology and disease; sORF-encoded microproteins

StudyTissue & cell · 2026-08-09

KPV attenuates adipogenesis and lipid metabolism through modulation of ROS-mediated AKT/mTORC1/PPARγ signaling